Prostate cancer is the second leading cause of cancer death among men. African-American men have the world's highest incidence of prostate cancer. Statistics show that one in four African-American males will develop prostate cancer, a rate 60 percent higher than the general population.

HHC has responded to these sobering statistics with a major commitment to provide cancer screening as one way to deal with the serious health needs of at-risk New Yorkers. HHC conducts education and evaluation efforts that include Prostate-Specific Antigen (PSA) blood tests to screen for prostate cancer. Screenings take place at locations throughout the five boroughs and are provided at no cost to participants.

Current guidelines call for all men over 50 to be tested once a year, and for high risk males—including all African-Americans—to be tested annually after 40. The Prostate-Specific Antigen Test (PSA) is a simple, painless blood test that is able to detect many prostate cancers in at-risk men.

Click here to locate an HHC facility near you for a prostate cancer screening.